Interprofessional Considerations in the Management of Pulmonary Arterial Hypertension

Learn patient-centered care practices for managing PAH from a multidisciplinary panel. Topics include presentation of PAH oral inhaled IV and SC treatments and strategies to manage iatrogenic and progression-related scenarios to improve quality of life for patients with PAH.

Share

Program Content

Activities

Prostacyclins in PAH
Parenteral Prostacyclins in PAH
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 26, 2021

Expires: March 25, 2022

FAQs on PAH
Frequently Asked Questions on PAH
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 30, 2021

Expires: March 29, 2022

Faculty

cover img faculity

James Christensen, PhD

Director
Translational Research, Oncology
Pfizer Global Research and Development
La Jolla, California

cover img faculity

James C. Coons, PharmD, FCCP, BCCP

Associate Professor
University of Pittsburgh School of Pharmacy
Clinical Pharmacist, Cardiology
University of Pittsburgh Medical Center-Presbyterian Hospital
PGY2 Cardiology Residency Program Director
Pittsburgh, Pennsylvania

cover img faculity

Martha Kingman, DNP, FNP-C

Nurse Practitioner
Pulmonary Hypertension Program
University of Texas Southwestern Medical Center at Dallas
Dallas, Texas

cover img faculity

Vallerie V. McLaughlin, MD

Endowed Professor of Cardiovascular Medicine
Interim Chief Clinic Officer
Ambulatory Care Services
Director
Pulmonary Hypertension Program
University of Michigan
Ann Arbor, Michigan

Provided by

ProCE Banner

Supporters

Actelion Pharmaceuticals a Janssen Pharm JJ